Peter A. Cooper

Johannesburg, GT, South Africa

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

A prospective observational study of developmental outcomes in survivors of neonatal hypoxic ischaemic encephalopathy in South Africa.

A prospective observational study of developmental outcomes in survivors of neonatal hypoxic ischaemic encephalopathy in South Africa.

Journal: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
Published: March 30, 2020

A review of -multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg, South Africa.

A review of -multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg, South Africa.

Journal: BMC pediatrics
Published: July 25, 2018

Assessment of developmental outcome in very low birth weight infants in Southern Africa using the Bayley Scales of Infant Development (III).

Assessment of developmental outcome in very low birth weight infants in Southern Africa using the Bayley Scales of Infant Development (III).

Journal: BMJ paediatrics open
Published: May 27, 2017

Use of the Bayley Scales of Infant and Toddler Development, Third Edition, to Assess Developmental Outcome in Infants and Young Children in an Urban Setting in South Africa.

Use of the Bayley Scales of Infant and Toddler Development, Third Edition, to Assess Developmental Outcome in Infants and Young Children in an Urban Setting in South Africa.

Journal: International scholarly research notices
Published: April 03, 2017

A review of delivery room resuscitation in very low birth weight infants in a middle income country.

A review of delivery room resuscitation in very low birth weight infants in a middle income country.

Journal: Maternal health, neonatology and perinatology
Published: December 05, 2016

Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naïve or previously treated with imiglucerase.

Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naïve or previously treated with imiglucerase.

Journal: Blood cells, molecules & diseases
Published: October 12, 2016

Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher disease.

Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher disease.

Journal: Blood cells, molecules & diseases
Published: July 14, 2016

Retrospective cross-sectional review of survival rates in critically ill children admitted to a combined paediatric/neonatal intensive care unit in Johannesburg, South Africa, 2013-2015.

Retrospective cross-sectional review of survival rates in critically ill children admitted to a combined paediatric/neonatal intensive care unit in Johannesburg, South Africa, 2013-2015.

Journal: BMJ open
Published: June 05, 2016

Strategies to reduce perinatal mortality.

Strategies to reduce perinatal mortality.

Journal: The Lancet. Global health
Published: October 26, 2015

Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease.

Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease.

Journal: American journal of hematology
Published: September 25, 2015

Comparison of morbidity and mortality of very low birth weight infants in a Central Hospital in Johannesburg between 2006/2007 and 2013.

Comparison of morbidity and mortality of very low birth weight infants in a Central Hospital in Johannesburg between 2006/2007 and 2013.

Journal: BMC pediatrics
Published: November 11, 2014

The challenge of reducing neonatal mortality in low- and middle-income countries.

The challenge of reducing neonatal mortality in low- and middle-income countries.

Journal: Pediatrics
Published: December 04, 2013
Showing 1-12 of 14

Last Updated: 09/26/2026